华森制药：控股股东一致行动人已累计减持1.77%股份

Core Viewpoint - The company announced a share reduction plan by its controlling shareholder and an associated investment fund, which will not affect the company's control structure [1] Group 1: Share Reduction Details - The controlling shareholder, You Hongtao, and Shanghai Tiancheng Investment Management Co., Ltd. will reduce their holdings by a total of 7,395,445 shares, representing 1.77% of the company's total share capital [1] - You Hongtao will reduce his holdings by 5,965,965 shares, accounting for 1.43% of the total share capital [1] - The Tiancheng Tianli No. 1 Private Securities Investment Fund will reduce its holdings by 1,429,480 shares, which is 0.34% of the total share capital [1] Group 2: Compliance and Control - The share reduction plan was executed within the pre-disclosed limit and did not lead to any change in the company's control [1]